LINC-PINT and breast cancer: To further bolster the reliability of our conclusions, exemplified by colorectal cancer and breast cancer, our GEO validation results indicated high expression of LINC-PINT in our colorectal cancer cells and low expression in breast cancer cells (Fig. 8A,B), consistent with our TCGA findings.